NASDAQ:AGIO - Agios Pharmaceuticals Stock Price, Forecast & News

Agios Pharmaceuticals' stock was trading at $40.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AGIO stock has decreased by 15.1% and is now trading at $34.70. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agios Pharmaceuticals in the last year. There are currently 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Agios Pharmaceuticals.

Agios Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Agios Pharmaceuticals.

Agios Pharmaceuticals Inc (NASDAQ:AGIO) released its quarterly earnings data on Thursday, February, 13th. The biopharmaceutical company reported ($1.60) earnings per share for the quarter, beating the Zacks' consensus estimate of ($1.72) by $0.12. The biopharmaceutical company earned $35.44 million during the quarter, compared to the consensus estimate of $33.72 million. Agios Pharmaceuticals had a negative net margin of 348.96% and a negative return on equity of 73.42%. The firm's revenue for the quarter was up 18.1% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.58) earnings per share. View Agios Pharmaceuticals' earnings history.

12 analysts have issued 12-month price targets for Agios Pharmaceuticals' stock. Their forecasts range from $49.00 to $79.00. On average, they anticipate Agios Pharmaceuticals' share price to reach $63.10 in the next year. This suggests a possible upside of 81.8% from the stock's current price. View analysts' price targets for Agios Pharmaceuticals.

Press coverage about AGIO stock has been trending very negative on Thursday, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Agios Pharmaceuticals earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned media headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutAgios Pharmaceuticals.

Some companies that are related to Agios Pharmaceuticals include Teva Pharmaceutical Industries (TEVA), Ono Pharmaceutical (OPHLF), Elanco Animal Health (ELAN), Beigene (BGNE), Mylan (MYL), Sarepta Therapeutics (SRPT), Catalent (CTLT), Perrigo (PRGO), Dr.Reddy's Laboratories (RDY), Ionis Pharmaceuticals (IONS), ACADIA Pharmaceuticals (ACAD), Jazz Pharmaceuticals (JAZZ), Horizon Therapeutics (HZNP), Ascendis Pharma A/S (ASND) and Bausch Health Companies (BHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Agios Pharmaceuticals investors own include Gilead Sciences (GILD), Celgene (CELG), bluebird bio (BLUE), Alibaba Group (BABA), Intercept Pharmaceuticals (ICPT), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), Micron Technology (MU) and AbbVie (ABBV).

Agios Pharmaceuticals trades on the NASDAQ under the ticker symbol "AGIO."

Shares of AGIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AGIO stock can currently be purchased for approximately $34.70.

Agios Pharmaceuticals has a market capitalization of $2.38 billion and generates $117.91 million in revenue each year. The biopharmaceutical company earns $-411,470,000.00 in net income (profit) each year or ($6.86) on an earnings per share basis. Agios Pharmaceuticals employs 482 workers across the globe. View additional information about Agios Pharmaceuticals.

The official website for Agios Pharmaceuticals is http://www.agios.com/.

Agios Pharmaceuticals' mailing address is 88 SIDNEY STREET, CAMBRIDGE MA, 02139. The biopharmaceutical company can be reached via phone at 617-649-8600 or via email at [email protected]